The distribution of the dipeptide carnosine was studied in the brain of the crested newt, Triturus carnifex, with immunohistochemical methods. Carnosine-Iike immunoreactivity (IR) is present in the cell bodies and processes of several areas of the central nervous system: in the telencephalon (especially in the medial pallium), in the diencephalon (pineal organ, thalamus, and hypothalamus), in the mesencephalon (optic tectum and tegmentum), and in the rhombencephalon (cerebellum, raphe region, and octavolateralis area). Double-labelling experiments show that carnosine IR is colocalized with tyrosine hydroxylase and neuropeptide Y IR in a few cells. Histochemical staining for heavy metals, the TIMM method, reveals that carnosine IR and TIMM labelling overlap in the medial pallium. These data indicate two primary conclusions: (a) In the crested newt brain, in contrast to those of mammals and birds, carnosine IR is not associated with glial cells but with neurons. Furthermore, carnosine is absent from the primary olfactory pathway in newts, (b) In the medial pallium of the crested newt, carnosine IR reliably identifies a population of neurons.

Keywords:
Carnosine, Immunohistochemistry, Triturus, Central nervous system
This content is only available via PDF.
© 1991 S. Karger AG, Basel
1991
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.